David C. Binder

2.3k total citations
37 papers, 1.4k citations indexed

About

David C. Binder is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, David C. Binder has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Immunology and 6 papers in Genetics. Recurrent topics in David C. Binder's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (6 papers). David C. Binder is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (6 papers). David C. Binder collaborates with scholars based in United States, Germany and Switzerland. David C. Binder's co-authors include Derek A. Wainwright, Lijie Zhai, Kristen L. Lauing, Galina Gritsina, Stefani Spranger, Francis J. Giles, Ayman Oweida, Sana D. Karam, Lynn E. Heasley and David Raben and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

David C. Binder

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Binder United States 17 759 681 298 210 175 37 1.4k
Burles A. Johnson United States 11 857 1.1× 772 1.1× 418 1.4× 176 0.8× 34 0.2× 34 1.5k
Nicholas N. Vahanian United States 21 764 1.0× 688 1.0× 594 2.0× 150 0.7× 57 0.3× 68 1.8k
Brendan Horton United States 13 1.6k 2.1× 1.6k 2.3× 484 1.6× 209 1.0× 32 0.2× 52 2.3k
Weiwei Wu China 15 738 1.0× 815 1.2× 476 1.6× 114 0.5× 20 0.1× 31 1.5k
Yasmeen Sarfraz United States 9 969 1.3× 904 1.3× 526 1.8× 336 1.6× 71 0.4× 13 1.8k
Mirna Balsamo Italy 15 723 1.0× 1.3k 1.9× 294 1.0× 51 0.2× 26 0.1× 17 1.7k
Camille Guillerey Australia 20 1.5k 2.0× 2.0k 3.0× 942 3.2× 134 0.6× 85 0.5× 26 3.2k
Edjah K. Nduom United States 17 691 0.9× 589 0.9× 496 1.7× 272 1.3× 760 4.3× 45 1.7k
Sarah A. Weiss United States 14 758 1.0× 753 1.1× 768 2.6× 111 0.5× 177 1.0× 22 1.8k
Richard G. Everson United States 20 580 0.8× 568 0.8× 310 1.0× 159 0.8× 575 3.3× 84 1.5k

Countries citing papers authored by David C. Binder

Since Specialization
Citations

This map shows the geographic impact of David C. Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Binder more than expected).

Fields of papers citing papers by David C. Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Binder. The network helps show where David C. Binder may publish in the future.

Co-authorship network of co-authors of David C. Binder

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Binder. A scholar is included among the top collaborators of David C. Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Binder. David C. Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dykstra, Michael, Smith Apisarnthanarax, George A. Poultsides, et al.. (2024). Local Therapy for Metastatic Colorectal Cancer. The Cancer Journal. 30(4). 280–289.
2.
Binder, David C., et al.. (2019). Studierenden-Monitoring (STUDMON), begleitender Projektbericht, Version 2, 24.09.2019. Institutional Repository (IHS Vienna). 1 indexed citations
3.
Oweida, Ayman, Mohammad K. Hararah, Andy V. Phan, et al.. (2018). Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration. Clinical Cancer Research. 24(21). 5368–5380. 209 indexed citations
4.
Zhai, Lijie, Erik Ladomersky, Kristen L. Lauing, et al.. (2017). Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival. Clinical Cancer Research. 23(21). 6650–6660. 144 indexed citations
5.
Zhai, Lijie, Erik Ladomersky, Kristen L. Lauing, et al.. (2017). Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma. Brain Behavior and Immunity. 62. 24–29. 42 indexed citations
6.
Binder, David C. & Derek A. Wainwright. (2017). The Boosting Potential of Bacteria in Cancer Immunotherapy. Trends in Molecular Medicine. 23(7). 580–582. 9 indexed citations
7.
Stokes, William A., David C. Binder, Bernard L. Jones, et al.. (2017). Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy. Journal of Neuroimmunology. 313. 118–122. 31 indexed citations
8.
Ladomersky, Erik, Matthew Genet, Lijie Zhai, et al.. (2016). Improving vaccine efficacy against malignant glioma. OncoImmunology. 5(8). e1196311–e1196311. 16 indexed citations
9.
Binder, David C., Ainhoa Arina, Tony Tu, et al.. (2016). Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium. OncoImmunology. 5(6). e1130207–e1130207. 14 indexed citations
10.
Binder, David C., Andrew A. Davis, & Derek A. Wainwright. (2015). Immunotherapy for cancer in the central nervous system: Current and future directions. OncoImmunology. 5(2). e1082027–e1082027. 61 indexed citations
11.
Mustafi, Devkumar, Sophie-Charlotte Gleber, Jesse Ward, et al.. (2015). IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. American Journal of Roentgenology. 205(3). W313–W319. 6 indexed citations
12.
Zhai, Lijie, Stefani Spranger, David C. Binder, et al.. (2015). Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy. Clinical Cancer Research. 21(24). 5427–5433. 234 indexed citations
13.
Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations
14.
Engels, Boris, Víctor H. Engelhard, John Sidney, et al.. (2013). Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity. Cancer Cell. 23(4). 516–526. 121 indexed citations
15.
Binder, David C. & Hans Schreiber. (2013). High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies. OncoImmunology. 2(12). e26704–e26704. 1 indexed citations
16.
Arina, Ainhoa, Karin Schreiber, David C. Binder, et al.. (2013). Adoptively Transferred Immune T Cells Eradicate Established Tumors despite Cancer-Induced Immune Suppression. The Journal of Immunology. 192(3). 1286–1293. 17 indexed citations
17.
Liu, Rebecca B., Boris Engels, Ainhoa Arina, et al.. (2012). Densely Granulated Murine NK Cells Eradicate Large Solid Tumors. Cancer Research. 72(8). 1964–1974. 45 indexed citations
18.
Tretiakova, Maria, Tatjana Antic, David C. Binder, et al.. (2012). Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Human Pathology. 44(4). 495–502. 39 indexed citations
19.
Moosmann, Peter, Jean‐Claude Fauchère, Jörg Halter, David C. Binder, & Urs Schanz. (2000). [Neonatal alloimmune thrombocytopenia due to a rare anti-HPA-1b antibody].. PubMed. 130(45). 1734–7. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burles A. Johnson Breakdown of academic impact, for papers by Nicholas N. Vahanian Breakdown of academic impact, for papers by Brendan Horton Breakdown of academic impact, for papers by Weiwei Wu Breakdown of academic impact, for papers by Yasmeen Sarfraz Breakdown of academic impact, for papers by Mirna Balsamo Breakdown of academic impact, for papers by Camille Guillerey Breakdown of academic impact, for papers by Edjah K. Nduom Breakdown of academic impact, for papers by Sarah A. Weiss Breakdown of academic impact, for papers by Richard G. Everson
Rankless by CCL
2026